Laura Bradigan
Psychiatric/Mental Health · Compton, CANPI 1407464522
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.8% of the total across 434 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 22 manufacturers, the largest accounting for just 11.9% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2024 at $4,401 and has fallen 74.9% since, to $1,105 in 2025. Among psychiatric/mental health clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 434 payments — averaging $20.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alkermes, Inc.$1K
- Johnson & Johnson$1K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$977
- Neurocrine Biosciences, Inc.$938
- AbbVie$845
- Otsuka America Pharmaceutical, Inc.$626
- plus $3K from 16 others
What the payments were for
- Food & beverage$8,902100%
- Education$180%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alkermes, Inc. | 45 | $1,065 |
| Johnson & Johnson | 53 | $1,028 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 56 | $977 |
| Neurocrine Biosciences, Inc. | 31 | $938 |
| AbbVie | 38 | $845 |
| Otsuka America Pharmaceutical, Inc. | 32 | $626 |
| Lundbeck LLC | 24 | $577 |
| Teva Pharmaceuticals USA, Inc. | 35 | $567 |
| Vanda Pharmaceuticals Inc. | 30 | $567 |
| Ironshore Pharmaceuticals Inc. | 21 | $484 |
| Corium, LLC | 22 | $343 |
| Axsome Therapeutics, Inc. | 6 | $195 |
| Tris Pharma Inc | 13 | $167 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $112 |
| E.r. Squibb & Sons, L.L.C. | 5 | $104 |
| Sage Therapeutics, LLC | 3 | $81 |
| Almatica Pharma LLC | 4 | $62 |
| Idorsia Pharmaceuticals US Inc | 3 | $52 |
| Sunovion Pharmaceuticals Inc. | 2 | $49 |
| Noven Therapeutics, LLC | 2 | $40 |
| Mirum Pharmaceuticals, Inc. | 1 | $23 |
| Boehringer Ingelheim | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$8,920 in reported general payments places this provider in the 95th percentile of 2,433 psychiatric/mental health providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Lurasidone Hcl | 14 | $16,618 |
| Seroquel XrQuetiapine Fumarate | 11 | $10,881 |
| Quetiapine Fumarate | 11 | $726 |
| Alprazolam | 19 | $352 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 12 | $250 |
| Bupropion XlBupropion Hcl | 11 | $104 |
| Buspirone Hcl | 13 | $81 |
| Risperidone | 11 | $58 |
Paid to pharmacies, not to this prescriber.
Other psychiatric/mental health in Compton
- Dalana GonzalezCompton$12K
- Carey MartinMillbrae$745K
- Liberty MaciasRedlands$288K
- Joshua BurgettSacramento$239K
- Jovita Ezirim-SalamialofojeLos Angeles$162K
- Angie-Kolleen TanThousand Oaks$159K
- Thy LamVista$121K
- Samantha PerkinsAnaheim$49K
- Yvette ElpidioOrange$43K
- Sarah KoLos Angeles$34K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.